180 results
Page 4 of 9
8-K
EX-2.1
xcx4bbqxyhguhsne2ghm
30 Aug 21
Catalent, Inc. Reports Fourth Quarter Fiscal 2021 Results
7:15am
8-K
EX-4.1
mcdazj zqekzsztycnp
22 Feb 21
Entry into a Material Definitive Agreement
4:27pm
8-K
EX-10.1
f0p9furzcg
22 Feb 21
Entry into a Material Definitive Agreement
4:27pm
8-K
EX-1.1
9n2gs
15 Jun 20
Entry into a Material Definitive Agreement
4:20pm
424B5
u841hqfw7rr6ieyyvtp
12 Jun 20
Prospectus supplement for primary offering
4:16pm
424B5
29rflcz5 uq
10 Jun 20
Prospectus supplement for primary offering
4:11pm
8-K
1huloy
30 Apr 20
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
4:43pm
8-K
EX-4.1
v4uqfafqu 8xtwqd
3 Mar 20
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-1.1
dpp35ytfs
6 Feb 20
Entry into a Material Definitive Agreement
4:22pm
424B5
72alrnkwvgxg0uq
3 Feb 20
Prospectus supplement for primary offering
4:26pm
8-K
EX-2.1
8l2a nm7w
3 Feb 20
Catalent, Inc. Reports Second Quarter Fiscal 2020 Results
7:40am